跳至主要内容
临床试验/NCT03900585
NCT03900585撤回不适用

Physical Activity and Fatigue in Danish Patients With Myasthenia Gravis - an Intervention Study

Rigshospitalet, Denmark0 个研究点开始时间: 2019年8月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
6 minutes walk test

研究概览

简要总结

The study is a controlled, randomized intervention trial. Patients are randomized into either an intervention group or a control group. The duration of the study is 10 weeks. Patients in the intervention group participate in a 10 weeks exercise program consisting of 150 minutes interval walking per week administered by an app on the patient's telephone. Patients in the control group live as usually, with a maximum of 30 minutes aerobic exercise per week.

Before and after the 10 weeks study period, patients (from both the intervention and the control group) participate in a 2 hours session of functional testing (e.g. walk tests, test of muscle strength ect.) at Rigshospitalet.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Able to provide signed informed consent.
  • Able to read and understand Danish or English.
  • Diagnosed with mild to moderate myasthenia gravis (I-IV on the Myasthenia Gravis Foundation of American Clinical Classification, MGFA).
  • Documented history of acetylcholine receptor (AChR) or Muscle Specific Kinase (MuSK) antibody positive, or abnormal repetitive nerve stimulation testing (decrement > 10%) on EMG or abnormal single fiber EMG (conduction block or jitter) or based on their clinical history and symptom improvement with acethylcholinesterase inhibitors.
  • If the patient is on oral corticosteroids, the dose must be stable for at least 1 month prior to inclusion.
  • If the patient is on cholinesterase inhibitors the dose must be stable 2 weeks prior to inclusion.

排除标准

  • MGFA grade V disease
  • Other disorders that are not related to MG, or drugs, that interfere with muscle strength, balance and fatigue.
  • Serious medical illness (e.g. uncontrolled insulin dependent diabetes mellitus, symptomatic coronary artery disease, and cancer).
  • Dementia or pregnancy.
  • Unspecified reasons judged by the investigator.

结局指标

主要结局

6 minutes walk test

时间窗: 6 minutes

Walk test

次要结局

  • Myasthenia gravis quality of life 15-item score (MG-QoL15)(3 minutes)
  • Myasthenia gravis composite score(30 minutes)
  • 30-s sit to stand test(30 seconds)
  • Myasthenia gravis activity of daily living profile (MG-ADL)(10 minutes)
  • Quantitative Myasthenia Gravis Score(45 minutes)
  • Multidimensional Fatigue Inventory (MFI-20)(5 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Linda Kahr Andersen

Master of Health Science, PhD student

Rigshospitalet, Denmark

相似试验